On August 23, 2021, Dong Sung Bio Pharm.Co.,Ltd. closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4,825 KRW | -1.03% |
|
-1.63% | -16.23% |
2023 | Dong Sung Bio Pharm.Co.,Ltd. announced that it has received KRW 14 billion in funding | CI |
2023 | Dong Sung Bio Pharm.Co.,Ltd. announced that it expects to receive KRW 14 billion in funding | CI |
1st Jan change | Capi. | |
---|---|---|
-16.23% | 8.01Cr | |
+20.76% | 4.38TCr | |
+28.00% | 2.28TCr | |
+20.25% | 1.56TCr | |
+18.82% | 1.43TCr | |
+55.83% | 1.3TCr | |
-0.05% | 678.76Cr | |
-12.70% | 641.27Cr | |
-8.87% | 572.55Cr | |
+14.65% | 568.66Cr |
- Stock Market
- Equities
- A002210 Stock
- News Dong Sung Bio Pharm.Co.,Ltd.
- Dong Sung Bio Pharm.Co.,Ltd. announced that it has received KRW 8.5 billion in funding from a group of investors